BioMarin Pharmaceutical Inc (BMRN.xnas)

traders view logo Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

BioMarin Pharmaceutical Inc (BMRN.xnas) Profile

BioMarin Pharmaceutical Inc (BMRN.xnas) is a world-leading biotechnology company headquartered in California, America. BioMarin operates in the United States, South America, Asia, and Europe with 34 offices locations in 20 countries and they will continue to expand into new markets and grow their team. BioMarin develops and commercialises first in class therapies for rare genetic diseases and it is a pioneer in treatments for debilitating and life-threatening conditions with business and research in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I) and the first to provide therapeutics for phenylketonuria (PKU). The company employes 3,000 people and has $1.7B (USD) in 2019 yearly revenue. BioMarin Pharmaceutical Inc stock (BMRN.xnas) is listed on NASDAQ and had a market capitalisation of $15.47B (USD) as of December 2021. The biotech sector has been in focus as of November 2021 due to the COVID-19 pandemic with drug approvals, with BioMarin being approved for Voxzogo injection. BioMarin plans to use the ongoing open-label extension studies to fulfil the post-marketing requirements of continued approval.

Holding cost
Trading hours in US Eastern Time

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

Why Trade BioMarin Pharmaceutical Inc (BMRN.xnas) with FP Markets? An Australian-regulated forex & CFD broker
go long or short
Go Long or Short

Increase your ability to profit in
all market conditions
Leverage options up to 20:1

direct market access
Direct Market Access (DMA) Execution

Real-time, transparent share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue

advanced platforms
Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with
superior client portal

24/5 Multilingual customer support
24/5 Multilingual
Customer Support

Award winning support &
personal account managers

global exposure
Global Exposure

Low margins and competitive commission
+10,000 products on global stocks
across 4 continents

earn dividends
Earn Dividends

On long positions
No ownership of physical
shares necessary

Bắt Đầu Giao Dịch sau một vài phút

bullet Truy cập trên 10.000 công cụ tài chính
bullet Tự động mở & đóng vị thế
bullet Lịch sự kiện tin tức & kinh tế
bullet Chỉ báo & biểu đồ kỹ thuật
bullet Bao gồm nhiều công cụ hơn

Bằng việc cung cấp email của mình, bạn đồng ý với chính sách về quyền riêng tư của FP Markets và nhận các tài liệu marketing trong tương lai từ FP Markets. Bạn có thể hủy đăng ký bất cứ lúc nào.

Source - database | Page ID - 16953

Get instant Updates in Telegram